Clinical Trial Update: Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial of X842 for reflux esophagitis has completed, with safety and efficacy data collected for evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• X842

Snippet

Sponsor: Jiangsu Sinorda Biomedicine Co., Ltd | Conditions: Reflux Esophagitis | Phase 2 | Status: COMPLETED